Author

A. Supramaniam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Idris· 3 shared G. Kelly· 2 shared A. A. Amarilla· 1 shared A. A. Khromykh· 1 shared A. Azuar· 1 shared A. Durgun· 1 shared A. Isaacs· 1 shared A. Kayabolen· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

A. Idris

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ACE2-Coated Virus-Like Particles Effectively Block SARS-CoV-2 Infection

C. Bayraktar, A. Kayabolen, A. Odabas, A. Durgun, I. Kok, K. Sevinc, A. Supramaniam, A. Idris, T. Bagci-Onder

This paper develops ACE2-coated virus-like particles (ACE2-VLPs) that effectively neutralize SARS-CoV-2, including variants, and show superior efficacy compared to ACE2-expressing extracellular vesicles.

bioRxiv · Sep 19, 2023 · PreprintBioengineering

Intranasal delivery of lipid nanoparticle encapsulated SARS-CoV-2 and RSV-targeting siRNAs reduces lung infection

A. Supramaniam, Y. Tayyar, D. T. Clarke, G. Kelly, K. V. Morris, N. A. McMillan, A. Idris

This paper develops an intranasal lipid nanoparticle (LNP) delivery system for siRNAs targeting SARS-CoV-2 and RSV, showing effective reduction of lung infection in mice.

bioRxiv · Jul 25, 2022 · PreprintMicrobiology

Complete protection by a single dose skin patch delivered SARS-CoV-2 spike vaccine

C. L. D. McMillan, J. J. Y. Choo, A. Idris, A. Supramaniam, N. Modhiran, A. A. Amarilla, A. Isaacs, S. T. M. Cheung, B. Liang, H. Bielefeldt-Ohmann, A. Azuar, D. Acharya, G. Kelly, G. J. P. Fernando, M. J. Landsberg, , D. A. Muller

A single dose of a SARS-CoV-2 spike vaccine delivered via a high-density microarray patch provides complete protection against a lethal virus challenge.

bioRxiv · May 30, 2021Microbiology